Viewing Study NCT03268057

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:33 PM
Ignite Modification Date: 2026-03-01 @ 1:27 PM
Study NCT ID: NCT03268057
Status: COMPLETED
Last Update Posted: 2022-05-02
First Post: 2017-08-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer
Sponsor: Vaccinex Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Small-Cell Lung View
None Carcinoma View
None Advanced View
None VX15/2503 View
None Semaphorin 4D View
None SEMA4D View
None safety tolerability View
None pharmacokinetics View
None monoclonal antibody View
None IO Failure View
None Immunotherapy Failure View
None Decline Chemo View